Key result
A 36-year-old female breast cancer patient undergoing chemotherapy presented with a rare synchronous case of hand, foot, and mouth disease and palmoplantar erythrodysesthesia.
Why the study?
Synchronous presentation of hand, foot, and mouth disease and palmoplantar erythrodysesthesia in cancer patients undergoing treatment had not previously been reported in the literature.
Case Report (n=1)
This case report describes the first known synchronous presentation of hand, foot, and mouth disease and palmoplantar erythrodysesthesia in a breast cancer patient undergoing chemotherapy.
Cancer patients may experience several dermatological symptoms during treatment.We describe a case of synchronous presentation of hand, foot, and mouth disease (HFMD) and palmoplantar erythrodysesthesia (PPE) in a breast cancer patient.A 36-year-old female breast cancer patient under chemotherapy presented to our consult with a 1-week history of painful palmoplantar lesions associated with the recent onset of fever and dry cough.Her daughter had been diagnosed with HFMD.There was a positive immunoglobulin M (IgM) and IgG serology for coxsackievirus.We performed two skin biopsies; one specimen was consistent with HFMD, and the other one was with PPE.To the best of our knowledge, the synchronous presentation of HFMD and PPE has not yet been reported in the literature to date.PPE and immunosuppression might have been responsible for the atypical presentation and clinical severity of HFMD.
No takes yet. Share an insight, caveat, or question.
Brazão et al. (2023) conducted a case report in Breast cancer, hand, foot, and mouth disease (HFMD), and palmoplantar erythrodysesthesia (PPE) (n=1). Chemotherapy was evaluated. A 36-year-old female breast cancer patient undergoing chemotherapy presented with a rare synchronous case of hand, foot, and mouth disease and palmoplantar erythrodysesthesia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: